Theranostics Market Size, Share, Trends, Opportunities, and Forecasts 2024 to 2031 | GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences

The Theranostics Market is anticipated to reach USD 4.2 billion by 2031 from USD 1.8 billion in 2022, at a CAGR of 11.3% during the forecast period.

DataM Intelligence has published a new research report on "Theranostics Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Segmentation, CAGR, business revenue competitive positioning of key companies, investigating elements such as product offerings, pricing strategies, financial performance, product portfolios, growth initiatives, and geographical reach. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/theranostics-market

The Theranostics Market refers to the industry focused on the integration of therapeutic and diagnostic solutions to provide personalized medicine. Theranostics involves using specific diagnostic tests to identify disease biomarkers, which then guide the application of targeted therapies. This approach is particularly common in oncology, where it enables tailored treatments based on the patient's unique biological characteristics. By combining diagnostics and therapeutics, theranostics enhances treatment effectiveness, reduces adverse effects, and improves patient outcomes. The market is driven by advances in molecular imaging, radiopharmaceuticals, and an increasing focus on personalized healthcare solutions.

Key Developments:

On February 22, 2022, Theragnostics announced that NephroScan, its radiodiagnostic imaging drug used to aid in the evaluation of renal parenchymal disorders in adult and pediatric patients, including term neonates, received Marketing Approval from the U.S. Food and Drug Administration (FDA). Earlier, on February 10, 2022, Theragnostics, which specializes in developing radiopharmaceuticals for cancer imaging and treatment, announced that its novel therapeutic agent I-123 PARPi (THG-009) had been awarded an Innovation Passport by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment of primary and recurrent Glioblastoma Multiforme (GBM). This recognition falls under the MHRA's Innovative Licensing and Access Pathway (ILAP), introduced in January 2021 to accelerate the development and access to innovative medicines in the UK.

On June 10, 2022, GE Healthcare highlighted its commitment to offering advanced molecular imaging solutions that improve access to precision health and theranostics, with a focus on enhancing patient outcomes in various areas of care, including prostate cancer-the most common cancer among men and the third most common overall. Unlike traditional therapies that are developed with the average patient in mind, theranostics revolutionizes treatment by integrating diagnosis and therapy into a single application, allowing for highly personalized, targeted treatments based on each patient's specific needs.

Research Process:

Both primary and secondary data sources have been used in the global Theranostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

List of the Key Players in the Theranostics Market:

GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc., CapVest Limited (Curium Pharma), Clarity Pharmaceuticals, Cardinal Health, LLC, Advanced Accelerator Applications, and ITM Isotopen Technologien München AG.

Segment Covered in the Theranostics Market:

By Application: Oncology, Neurological Disorder, Cardiovascular Disease and Others

By Radioisotopes: Technetium-99, Gallium-68, Lutetium (Lu) 177, Iodine-131, Zirconium-89 , Y-90 and Others

By End User: Hospitals, Cancer Research Institutes, Diagnostic Centers and Others

Regional Analysis:

The global Theranostics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/theranostics-market

Regional Analysis:

The global Theranostics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Theranostics Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Theranostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Theranostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/theranostics-market

Frequently Asked Questions

Q1) How Big is the Theranostics Market?

A) Global theranostics market reached USD 1.8 billion in 2022 and is expected to witness lucrative growth by reaching up to USD 4.2 billion by 2031.

Q2) Who are the key players of Theranostics Market?

A) GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc., CapVest Limited (Curium Pharma), Clarity Pharmaceuticals, Cardinal Health, LLC, Advanced Accelerator Applications, and ITM Isotopen Technologien München AG.

Q3) What are the regions covered in this report?

A) The global Theranostics Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa

4) What are the Segments Coverd in this report?

A) The Theranostics market is segmented as Application, Radioisotopes, End User

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.